Your browser doesn't support javascript.
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Barrett, Jordan R; Belij-Rammerstorfer, Sandra; Dold, Christina; Ewer, Katie J; Folegatti, Pedro M; Gilbride, Ciaran; Halkerston, Rachel; Hill, Jennifer; Jenkin, Daniel; Stockdale, Lisa; Verheul, Marije K; Aley, Parvinder K; Angus, Brian; Bellamy, Duncan; Berrie, Eleanor; Bibi, Sagida; Bittaye, Mustapha; Carroll, Miles W; Cavell, Breeze; Clutterbuck, Elizabeth A; Edwards, Nick; Flaxman, Amy; Fuskova, Michelle; Gorringe, Andrew; Hallis, Bassam; Kerridge, Simon; Lawrie, Alison M; Linder, Aline; Liu, Xinxue; Madhavan, Meera; Makinson, Rebecca; Mellors, Jack; Minassian, Angela; Moore, Maria; Mujadidi, Yama; Plested, Emma; Poulton, Ian; Ramasamy, Maheshi N; Robinson, Hannah; Rollier, Christine S; Song, Rinn; Snape, Matthew D; Tarrant, Richard; Taylor, Stephen; Thomas, Kelly M; Voysey, Merryn; Watson, Marion E E; Wright, Daniel; Douglas, Alexander D; Green, Catherine M.
  • Barrett JR; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Belij-Rammerstorfer S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Ewer KJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gilbride C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Halkerston R; Public Health England, Salisbury, UK.
  • Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Jenkin D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Daniel.Jenkin@ndm.ox.ac.uk.
  • Stockdale L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Verheul MK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Bellamy D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Berrie E; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Bittaye M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Carroll MW; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Cavell B; Public Health England, Salisbury, UK.
  • Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Edwards N; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Flaxman A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gorringe A; Public Health England, Salisbury, UK.
  • Hallis B; Public Health England, Salisbury, UK.
  • Kerridge S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Lawrie AM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Madhavan M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Makinson R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Mellors J; Public Health England, Salisbury, UK.
  • Minassian A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Poulton I; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Tarrant R; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Taylor S; Public Health England, Salisbury, UK.
  • Thomas KM; Public Health England, Salisbury, UK.
  • Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Watson MEE; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Wright D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Douglas AD; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Green CM; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nat Med ; 27(6): 1113, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1262007
Semantic information from SemMedBD (by NLM)
1. ChAdOx1 nCoV-19 AUGMENTS Antibody Formation
Subject
ChAdOx1 nCoV-19
Predicate
AUGMENTS
Object
Antibody Formation
2. ChAdOx1 nCoV-19 AUGMENTS Antibody Formation
Subject
ChAdOx1 nCoV-19
Predicate
AUGMENTS
Object
Antibody Formation

Full text: Available Collection: International databases Database: MEDLINE Type of study: Randomized controlled trials Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01372-z

Full text: Available Collection: International databases Database: MEDLINE Type of study: Randomized controlled trials Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01372-z